<DOC>
	<DOCNO>NCT01336205</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety tolerability NKTR-118 treatment opioid-induced constipation ( OIC ) patient non-cancer-related pain .</brief_summary>
	<brief_title>Assessment Long-term Safety Patients With Non-cancer-related Pain Opioid-induced Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naloxegol</mesh_term>
	<criteria>Provision write informed consent prior studyspecific procedure . NEW PATIENTS ONLY : Selfreported active symptom OIC screen ( &lt; 3 SBMs/week experience &gt; 1 report symptom hard/lumpy stool , strain , sensation incomplete evacuation/anorectal obstruction least 25 % BMs previous 4 week ) ; Documented confirm OIC ( &lt; 3 SBMs/week average 2week OIC confirmation period . PATIENTS ENROLLING FROM OTHER NKTR118 STUDIES : Receiving stable maintenance opioid regimen consist total daily dose 30 mg 1000 mg oral morphine , equianalgesic amount ( ) 1 opioid therapy . FOR PATIENTS RANDOMIZED TO RECEIVE NKTR118 : Willingness stop laxative bowel regimen include prune juice herbal product throughout 52week treatment period , use bisacodyl rescue medication BM occur within least 72 hour last record BM . Patients receive Opioid regimen treatment pain related cancer . History cancer within 5 year first study visit exception basal cell cancer squamous cell skin cancer . Medical condition treatment associate diarrhea , intermittent loose stool , constipation . Other issue relate gastrointestinal tract could impose risk patient . Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Non-Cancer-Related Pain</keyword>
	<keyword>Opioid-Induced Constipation</keyword>
</DOC>